# Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences
Ticker: PHAT
Company: Phathom Pharmaceuticals
Source: Phathom Pharmaceuticals
Published: 2026-04-06 12:00 EST
Original Source URL: https://investors.phathompharma.com
## Summary

FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to

## Article Body
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to
## Recent Company News
- 2026-05-20 12:00 EST — [Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting](https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-highlights-breadth-of-independent-vonoprazan-research-at-digestive-disease-week-2026-annual-meeting) — Source: Phathom Pharmaceuticals
- 2026-05-01 12:00 EST — [Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting](https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-to-highlight-voqueznar-vonoprazan-at-ddw-2026-annual-meeting) — Source: Phathom Pharmaceuticals
- 2026-04-30 10:59 EST — [Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update) — Source: Phathom Pharmaceuticals
- 2026-04-20 12:00 EST — [Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026](https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-to-report-first-quarter-2026-financial-results-and-provide-business-update-on-thursday-april-30-2026) — Source: Phathom Pharmaceuticals
- 2026-04-06 12:00 EST — [Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/PHAT/phathom-pharmaceuticals-to-participate-in-upcoming-investor-conferences) — Source: Phathom Pharmaceuticals
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)